- Home
- GRX
as 03-28-2025 4:00pm EST
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 156.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 39.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.73 - $10.40 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of The Gabelli Healthcare & Wellness Trust of Beneficial Interest (GRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | GRX | 10% Owner | Mar 18 '25 | Buy | $9.88 | 549 | $5,424.12 | 1,956,488 | |
| Saba Capital Management, L.P. | GRX | 10% Owner | Mar 11 '25 | Buy | $10.09 | 100 | $1,009.00 | 1,956,488 | |
| Saba Capital Management, L.P. | GRX | 10% Owner | Mar 4 '25 | Buy | $9.96 | 4,388 | $43,704.48 | 1,956,488 | |
| Saba Capital Management, L.P. | GRX | 10% Owner | Feb 27 '25 | Buy | $9.89 | 5,752 | $56,839.31 | 1,956,488 | |
| GABELLI MARIO J | GRX | Director | Feb 20 '25 | Buy | $10.20 | 1,000 | $10,202.00 | 236,925 | |
| Saba Capital Management, L.P. | GRX | 10% Owner | Jan 28 '25 | Buy | $10.27 | 1,500 | $15,405.00 | 1,956,488 | |
| GABELLI MARIO J | GRX | Director | Jan 22 '25 | Buy | $9.95 | 1,000 | $9,950.00 | 236,925 | |
| GABELLI MARIO J | GRX | Director | Jan 16 '25 | Buy | $9.80 | 4,000 | $39,200.00 | 236,925 | |
| Saba Capital Management, L.P. | GRX | 10% Owner | Jan 10 '25 | Buy | $9.57 | 14,833 | $141,951.81 | 1,956,488 | |
| VANEKRIS ANTHONIE C | GRX | Director | Jan 8 '25 | Sell | $9.65 | 1,115 | $10,759.75 | 11,185 |
Latest The Gabelli Healthcare & Wellness Trust of Beneficial Interest News
GRX Breaking Stock News: Dive into GRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Gabelli Healthcare & WellnessRx Trust Declares First Quarter Distribution of $0.15 Per Share
GlobeNewswire
2 months ago
UPDATE - United Kingdom Investment Trusts
GlobeNewswire
2 months ago
Discount Doctor to Visit United Kingdom in Support of Investment Trusts
GlobeNewswire
4 months ago
Gabelli Healthcare & WellnessRx Trust Declares Fourth Quarter Distribution of $0.15 Per Share
GuruFocus.com
5 months ago
Saba Capital Management, L.P. Increases Stake in Gabelli Healthcare & WellnessRx Trust
GuruFocus.com
6 months ago
Saba Capital Management's Strategic Acquisition in Gabelli Healthcare & WellnessRx Trust
GlobeNewswire
7 months ago
Gabelli Healthcare & WellnessRx Trust Declares Third Quarter Distribution of $0.15 Per Share
CNW Group
10 months ago
HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
Compare GRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.